期刊文献+

The value of serum levels of aldosterone in predicting in-stent restenosis after coronary stent implantation 被引量:1

The value of serum levels of aldosterone in predicting in-stent restenosis after coronary stent implantation
原文传递
导出
摘要 In recent years,Percutaneous coronary intervention(PCI) as an effective treatment for coronary heart disease has been widely carried out in China.However,people is still confronted with the problem that the incidence of in-stent restenosis (ISR) after PCI.Some risk factors of coronary heart disease have been obviously known,but the in-dependent predictor factors for the ISR has not been clear.Clarifying risk factors for ISR to establish interfering meas-ures may be a new direction for PCI treatment in the future.At present,it has been reported that aldosterone (ALD) may be involved in ISR.In order to further investigate the relationship between the serum ALD levels and ISR,our re-search was to determine the ALD and other serum markers to explore the impact factors of ISR.Methods We meas-ured serum ALD,high sensitivity C-reactive protein (hs-CRP) ,adiponectin (ADP) and other indicators in 258 pa-tients with coronary stenting,and made routine follow-up for 6-9 months to perform coronary angiography.According to the results of coronary angiography,all patients were divided into restenosis group and non-restenosis group.We an-alyzed the relationship between ALD,other indicators and ISR to explore whether serum ALD was an independent risk factor ISR.Results Serum ALD levels were significantly higher in restenosis group than non-restenosis group.Logis-tic regression analysis showed that diabetes,ALD,hs-CRP and complex lesions were also independent risk factors for ISR (P < 0.05) ,while the ADP was as a protective factor for ISR (P < 0.05) .Conclusions ALD is one of inde-pendent risk factors for ISR after undergoing coronary stent implantation in patients.It has the possibility of becoming one new method in this medical field. In recent years,Percutaneous coronary intervention(PCI) as an effective treatment for coronary heart disease has been widely carried out in China.However,people is still confronted with the problem that the incidence of in-stent restenosis (ISR) after PCI.Some risk factors of coronary heart disease have been obviously known,but the in-dependent predictor factors for the ISR has not been clear.Clarifying risk factors for ISR to establish interfering meas-ures may be a new direction for PCI treatment in the future.At present,it has been reported that aldosterone (ALD) may be involved in ISR.In order to further investigate the relationship between the serum ALD levels and ISR,our re-search was to determine the ALD and other serum markers to explore the impact factors of ISR.Methods We meas-ured serum ALD,high sensitivity C-reactive protein (hs-CRP) ,adiponectin (ADP) and other indicators in 258 pa-tients with coronary stenting,and made routine follow-up for 6-9 months to perform coronary angiography.According to the results of coronary angiography,all patients were divided into restenosis group and non-restenosis group.We an-alyzed the relationship between ALD,other indicators and ISR to explore whether serum ALD was an independent risk factor ISR.Results Serum ALD levels were significantly higher in restenosis group than non-restenosis group.Logis-tic regression analysis showed that diabetes,ALD,hs-CRP and complex lesions were also independent risk factors for ISR (P < 0.05) ,while the ADP was as a protective factor for ISR (P < 0.05) .Conclusions ALD is one of inde-pendent risk factors for ISR after undergoing coronary stent implantation in patients.It has the possibility of becoming one new method in this medical field.
出处 《South China Journal of Cardiology》 CAS 2010年第2期84-88,共5页 岭南心血管病杂志(英文版)
关键词 ALDOSTERONE percutaneous coronary intervention drug-eluting stents in-stent restenosis aldosterone percutaneous coronary intervention drug-eluting stents in-stent restenosis
  • 相关文献

参考文献10

  • 1Amano T,Matsubara T,Izawa H,et al.Impact of plasma aldo-sterone levels for prediction of in-stent restenosis. The American Journal of Cardiology . 2006
  • 2Jeong Y,Chaupin DF,Matsushita K,et al.Aldosterone acti-vates endothelial exocytosis. Proc.Natl Acad Sci U S A . 2009
  • 3Mutoh A,Isshiki M,Fujita T.Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells. HypertensRes . 2008
  • 4Hong YJ,Jeong MH,Lim SY,et al.Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting. The American Journal of Cardiology . 2006
  • 5Ryan TJ,Faxon DP,Gunnar RM,et al.Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic cardiovascular Procedures (Subcommittee on Percutaneous Translu. Journal of the American College of Cardiology . 1988
  • 6Matsuda M,Shimomura I,Sata M,et al.Role of adiponectin in preventing vascular stenosis, the missing link of adipo-vascular axis. Journal of Biological Chemistry . 2002
  • 7Kitta Y,Obata JE,Takano H,Nakamura T,Kodama Y,Fujioka D,Saito Y,Kawabata K,Mende A,Kobayashi T,Kugiyama K.Echolucent carotid plaques predict in-stent restenosis after bare metal stenting in native coronary arteries. Atherosclerosis . 2008
  • 8K. Nishio,M. Sakurai,T. Kusuyama.A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes. Diabetes Care . 2006
  • 9Shioji K,Moriwaki S,Takeuchi Y, et al.Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention. Circulation . 2007
  • 10Stone GW,Ellis SG,Cox DA,et al.A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. New England Journal of Homeopathy . 2004

同被引文献3

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部